Cointime

Interline Therapeutics

company

About

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

  • 11 - 50

Highlights

Total Funding Amount
$92M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$59.50M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

It uses genomics, proteomics, structural biology, and computational chemistry to map and modulate protein communities. Interline leverages recent advancements in these technologies, as well as collaborations with leading academic groups, to develop a precision medicine platform focused on three essential areas, genomics, communities, and modulators.

The South San Francisco, California-located company was founded by Zach Sweeney in 2020.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$92M
Interline Therapeutics has raised a total of $92M in funding over 2 rounds. Their latest funding was raised on May 13, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 13, 2021 Series A $59.50M 1 ARCH Venture Partners — Detail
Mar 16, 2021 Seed $32.50M 1 ARCH Venture Partners — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Interline Therapeutics is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series A
Cointime
Chủ Đề
Công Ty